Skip to main content
PMC home page
Heart logoLink to Heart
. 2000 Apr;83(4):439–443. doi: 10.1136/heart.83.4.439

Neurohormonal activation late after cavopulmonary connection

V Hjortdal 1, E Stenbog 1, H Ravn 1, K Emmertsen 1, K Jensen 1, E Pedersen 1, K Olsen 1, O Hansen 1, K Sorensen 1
PMCID: PMC1729373  PMID: 10722548

Abstract

OBJECTIVE—To determine whether patients with cavopulmonary connection have higher levels of vasoactive/water-salt regulating hormones and if so, whether hormone levels are related to postoperative haemodynamics and postoperative follow up.
DESIGN—Cross sectional study.
SETTING—University hospital.
PATIENTS—20 patients (New York Heart Association functional class I-II), mean age 11 years (range 4 to 22), were studied at a mean of 2 years (0.5 to 6) after a total cavopulmonary connection (TCPC, n = 12) or a bidirectional Glenn anastomosis (BDG, n = 8).
INTERVENTIONS—Cardiac catheterisation was performed and blood samples were drawn. Control blood samples were drawn from 33 healthy children, mean age 12 years (6 to 16).
MAIN OUTCOME MEASURES—Plasma levels of angiotensin II, renin, aldosterone, arginine, vasopressin, atrial natriuretic factor (ANF), brain natriuretic peptide (BNP).
RESULTS—All neurohormones were significantly increased in both TCPC and BDG patients (p < 0.05), with a fourfold increase in angiotensin II, renin, and aldosterone, and a twofold increase in vasopressin, ANF, and BNP (compared with healthy controls). There was no correlation between haemodynamic variables and hormone levels. Angiotensin II and renin were inversely correlated with time to follow up. All subjects over 15 years (n = 5) had normal neurohormonal levels.
CONCLUSIONS—Neurohormones were raised for years after successful cavopulmonary operations but lower levels were observed with time on follow up. This supports the hypothesis that neurohormonal activation is primarily related to altered postoperative physiology and that adaptation takes place over time.


Keywords: neurohormones; cavopulmonary connection; congenital heart disease; paediatric cardiology

Full Text

The Full Text of this article is available as a PDF (104.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez Kindelan A., Pérez Navero J. L., Ibarra de la Rosa I., Concha Ruiz M., Montilla López P., Romanos Lezcano A. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Crit Care Med. 1994 Nov;22(11):1754–1761. [PubMed] [Google Scholar]
  2. Bengur A. R., Beekman R. H., Rocchini A. P., Crowley D. C., Schork M. A., Rosenthal A. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation. 1991 Feb;83(2):523–527. doi: 10.1161/01.cir.83.2.523. [DOI] [PubMed] [Google Scholar]
  3. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  4. Dilsizian V., Bonow R. O. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993 Jan;87(1):1–20. doi: 10.1161/01.cir.87.1.1. [DOI] [PubMed] [Google Scholar]
  5. Fiselier T. J., Lijnen P., Monnens L., van Munster P., Jansen M., Peer P. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood. Eur J Pediatr. 1983 Oct;141(1):3–7. doi: 10.1007/BF00445660. [DOI] [PubMed] [Google Scholar]
  6. Geggel R. L. Update on the modified Fontan procedure. Curr Opin Cardiol. 1997 Jan;12(1):51–62. doi: 10.1097/00001573-199701000-00009. [DOI] [PubMed] [Google Scholar]
  7. Harrison D. A., Liu P., Walters J. E., Goodman J. M., Siu S. C., Webb G. D., Williams W. G., McLaughlin P. R. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol. 1995 Oct;26(4):1016–1021. doi: 10.1016/0735-1097(95)00242-7. [DOI] [PubMed] [Google Scholar]
  8. Hiramatsu T., Imai Y., Takanashi Y., Seo K., Terada M., Nakazawa M. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure. Ann Thorac Surg. 1998 Mar;65(3):761–764. doi: 10.1016/s0003-4975(97)01352-0. [DOI] [PubMed] [Google Scholar]
  9. Jensen K. T., Carstens J., Ivarsen P., Pedersen E. B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest. 1997 Oct;57(6):529–540. doi: 10.3109/00365519709084604. [DOI] [PubMed] [Google Scholar]
  10. Kappelgaard A. M., Nielsen M. D., Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta. 1976 Mar 15;67(3):299–306. doi: 10.1016/0009-8981(76)90338-7. [DOI] [PubMed] [Google Scholar]
  11. Kato H., Suzuki H., Tajima S., Ogata Y., Tominaga T., Sato A., Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991 Jan;9(1):17–22. [PubMed] [Google Scholar]
  12. Kelley J. R., Mack G. W., Fahey J. T. Diminished venous vascular capacitance in patients with univentricular hearts after the Fontan operation. Am J Cardiol. 1995 Jul 15;76(3):158–163. doi: 10.1016/s0002-9149(99)80049-6. [DOI] [PubMed] [Google Scholar]
  13. Komajda M., Pousset F., Isnard R., Lechat P. The role of the neurohormonal system in heart failure. Heart. 1998 Jun;79(Suppl 2):S17–S23. doi: 10.1136/hrt.79.2008.17s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kouatli A. A., Garcia J. A., Zellers T. M., Weinstein E. M., Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997 Sep 2;96(5):1507–1512. doi: 10.1161/01.cir.96.5.1507. [DOI] [PubMed] [Google Scholar]
  15. Levin E. R., Gardner D. G., Samson W. K. Natriuretic peptides. N Engl J Med. 1998 Jul 30;339(5):321–328. doi: 10.1056/NEJM199807303390507. [DOI] [PubMed] [Google Scholar]
  16. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998 May;135(5 Pt 1):825–832. doi: 10.1016/s0002-8703(98)70041-9. [DOI] [PubMed] [Google Scholar]
  17. Mainwaring R. D., Lamberti J. J., Moore J. W., Billman G. F., Nelson J. C. Comparison of the hormonal response after bidirectional Glenn and Fontan procedures. Ann Thorac Surg. 1994 Jan;57(1):59–64. doi: 10.1016/0003-4975(94)90365-4. [DOI] [PubMed] [Google Scholar]
  18. McDonagh T. A., Robb S. D., Murdoch D. R., Morton J. J., Ford I., Morrison C. E., Tunstall-Pedoe H., McMurray J. J., Dargie H. J. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998 Jan 3;351(9095):9–13. doi: 10.1016/s0140-6736(97)03034-1. [DOI] [PubMed] [Google Scholar]
  19. Morgan H. E., Baker K. M. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation. 1991 Jan;83(1):13–25. doi: 10.1161/01.cir.83.1.13. [DOI] [PubMed] [Google Scholar]
  20. Nagaoka H., Innami R., Arai H. Effects of pulsatile cardiopulmonary bypass on the renin-angiotensin-aldosterone system following open heart surgery. Jpn J Surg. 1988 Jul;18(4):390–396. doi: 10.1007/BF02471462. [DOI] [PubMed] [Google Scholar]
  21. Nagaya N., Nishikimi T., Uematsu M., Kyotani S., Satoh T., Nakanishi N., Matsuo H., Kangawa K. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J. 1998 Aug;136(2):297–301. doi: 10.1053/hj.1998.v136.89729. [DOI] [PubMed] [Google Scholar]
  22. Pedersen E. B., Danielsen H., Spencer E. S. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol. 1984;26(5):543–547. doi: 10.1007/BF00543482. [DOI] [PubMed] [Google Scholar]
  23. Perrault H., Miró J., Davignon A., Béland M., Armstrong B., Thibault G., Cantin M., Chartrand C. Decreased plasma atriopeptin response to volume-overloading maneuvers and exercise after atriopulmonary anastomosis of Fontan. Am J Cardiol. 1992 May 15;69(16):1325–1328. doi: 10.1016/0002-9149(92)91230-2. [DOI] [PubMed] [Google Scholar]
  24. Pitt B., Segal R., Martinez F. A., Meurers G., Cowley A. J., Thomas I., Deedwania P. C., Ney D. E., Snavely D. B., Chang P. I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. doi: 10.1016/s0140-6736(97)01187-2. [DOI] [PubMed] [Google Scholar]
  25. Rask-Madsen J., Bruusgaard A., Munck O., Nielsen M. D., Worning H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal bypass operation. Scand J Gastroenterol. 1974;9(5):417–426. [PubMed] [Google Scholar]
  26. Reybrouck T., Rogers R., Weymans M., Dumoulin M., Vanhove M., Daenen W., Van der Hauwaert L., Gewillig M. Serial cardiorespiratory exercise testing in patients with congenital heart disease. Eur J Pediatr. 1995 Oct;154(10):801–806. doi: 10.1007/BF01959785. [DOI] [PubMed] [Google Scholar]
  27. Rosenthal M., Bush A., Deanfield J., Redington A. Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation. 1995 Jan 15;91(2):372–378. doi: 10.1161/01.cir.91.2.372. [DOI] [PubMed] [Google Scholar]
  28. Stewart J. M., Gewitz M. H., Clark B. J., Seligman K. P., Romano A., Zeballos G. A., Chang A., Murdison K., Woolf P. K., Norwood W. I. The role of vasopressin and atrial natriuretic factor in postoperative fluid retention after the Fontan procedure. J Thorac Cardiovasc Surg. 1991 Dec;102(6):821–829. [PubMed] [Google Scholar]
  29. Thomassen A. R., Bagger J. P., Nielsen T. T., Pedersen E. B. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol. 1987 Dec;17(3):267–279. doi: 10.1016/0167-5273(87)90075-1. [DOI] [PubMed] [Google Scholar]
  30. Troutman W. B., Barstow T. J., Galindo A. J., Cooper D. M. Abnormal dynamic cardiorespiratory responses to exercise in pediatric patients after Fontan procedure. J Am Coll Cardiol. 1998 Mar 1;31(3):668–673. doi: 10.1016/s0735-1097(97)00545-7. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES